DE69417717D1 - Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen - Google Patents

Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen

Info

Publication number
DE69417717D1
DE69417717D1 DE69417717T DE69417717T DE69417717D1 DE 69417717 D1 DE69417717 D1 DE 69417717D1 DE 69417717 T DE69417717 T DE 69417717T DE 69417717 T DE69417717 T DE 69417717T DE 69417717 D1 DE69417717 D1 DE 69417717D1
Authority
DE
Germany
Prior art keywords
vaccine
protection
herpes virus
virus infections
equine herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69417717T
Other languages
English (en)
Other versions
DE69417717T2 (de
Inventor
Martha Jacoba Willemse
Paulus Jacobus An Sondermeijer
Lesley Nickolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69417717D1 publication Critical patent/DE69417717D1/de
Publication of DE69417717T2 publication Critical patent/DE69417717T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69417717T 1993-12-20 1994-12-15 Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen Expired - Lifetime DE69417717T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203584 1993-12-20

Publications (2)

Publication Number Publication Date
DE69417717D1 true DE69417717D1 (de) 1999-05-12
DE69417717T2 DE69417717T2 (de) 1999-10-07

Family

ID=8214224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417717T Expired - Lifetime DE69417717T2 (de) 1993-12-20 1994-12-15 Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen

Country Status (5)

Country Link
US (1) US5674499A (de)
JP (1) JP3710838B2 (de)
AT (1) ATE178654T1 (de)
DE (1) DE69417717T2 (de)
ES (1) ES2132330T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
WO2000046386A2 (en) * 1999-02-03 2000-08-10 The Children's Medical Center Corporation Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
AU2982300A (en) 1999-02-03 2000-08-25 Children's Medical Center Corporation Gene repair involving (in vivo) excision of targeting dna
EP1394258A1 (de) * 2002-08-30 2004-03-03 Geneart GmbH Nicht-menschliche Herpesviren als Vektoren
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8916371B2 (en) * 2012-03-20 2014-12-23 Merial Limited Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) * 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine

Also Published As

Publication number Publication date
DE69417717T2 (de) 1999-10-07
ATE178654T1 (de) 1999-04-15
ES2132330T3 (es) 1999-08-16
US5674499A (en) 1997-10-07
JPH07236489A (ja) 1995-09-12
JP3710838B2 (ja) 2005-10-26

Similar Documents

Publication Publication Date Title
ATE73348T1 (de) Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung.
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
FR2647808B1 (fr) Poxvirus recombinant et vaccin contre le virus de l'herpes contenant ce poxvirus
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
BR9305617A (pt) Uso de isolados de bacillus thuringiensis para controlar pragas na familia dos afidideos
ATE241994T1 (de) Hsv-mutant-1716 zur behandlung von mesotheliomen
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
DE3485873T2 (de) Herpes simplex virus subunitimpfstoff.
DE69417717T2 (de) Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen
WO2000061736A3 (en) Recombinant and mutant marek's disease virus
NO983946L (no) Parapoxviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
FR2702152B1 (fr) Virus recombinants et leur utilisation en thérapie génique.
DK0507179T3 (da) Equine herpesvira (EHV), der indeholder fremmed
HUP0102861A2 (hu) Attenuált lóherpeszvírus
HUP0001991A2 (hu) Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák
ATE171218T1 (de) Rekombinanter varicella-zoster-virus-vektor
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
GB2359083A (en) Mutant herpes simplex viruses and uses thereof
ZA9110022B (en) Cell free marek's disease virus vaccine
ATE232238T1 (de) Synthetische promotoren von herpes simplex virus
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL